Wednesday, June 18, 2008 5:23:47 PM
Pluristem Therapeutics Files $15M Common Stock Shelf >PSTI Last update: 6/18/2008 5:19:03 PM DOW JONES NEWSWIRES
Pluristem Therapeutics Inc. (PSTI) on Wednesday registered with the Securities and Exchange Commission to sell from time to time up to $15 million of common stock and warrants.
The Israel-based stem cell production technology company said it intends to use the net proceeds for research and product development activities, and for working capital and other general corporate purposes.
No underwriters were listed in the SEC filing.
Shares of the company closed Wednesday at $1.63 each, down 11 cents, or 6.32%. -Denise Jia, Dow Jones Newswires; 202-862-1359; denise.jia@dowjones.com (END) Dow Jones NewswiresJune 18, 2008 17:19 ET (21:19 GMT)
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM